|
"perng rp"的相關文件
顯示項目 6-55 / 58 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2012-11 |
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia
|
Lan, Q;Hsiung, CA;Matsuo, K;Hong, YC;Seow, A;Wang, Z;Hosgood, HD;Chen, K;Wang, JC;Chatterjee, N;Hu, W;Wong, MP;Zheng, W;Caporaso, N;Park, JY;Chen, CJ;Kim, YH;Kim, YT;Landi, MT;Shen, H;Lawrence, C;Burdett, L;Yeager, M;Yuenger, J;Jacobs, KB;Chang, IS;Mitsudomi, T;Kim, HN;Chang, GC;Bassig, BA;Tucker, M;Wei, F;Yin, Z;Wu, C;An, SJ;Qian, B;Lee, VHF;Lu, D;Liu, J;Jeon, HS;Hsiao, CF;Sung, JS;Kim, JH;Gao, Y-T;Tsai, YH;Jung, YJ;Guo, H;Hu, Z;Hutchinson, A;Wang, WC;Klein, R;Chung, CC;Oh, IJ;Chen, KY;Berndt, SI;He, X;Wu, W;Chang, J;Zhang, XC;Huang, MS;Zheng, H;Wang, J;Zhao, X;Li, Y;Choi, JE;Su, WC;Park, KH;Sung, SW;Shu, XO;Chen, YM;Liu, L;Kang, CH;Hu, L;Chen, CH;Pao, W;Kim, YC;Yang, TY;Xu, J;Guan, P;Tan, W;Su, J;Wang, CL;Li, H;Sihoe, ADL;Zhao, Z;Chen, Y;Choi, YY;Hung, JY;Kim, JS;Yoon, HI;Cai, Q;Lin, CC;Park, IK;Xu, P;Dong, J;Kim, C;He, Q;Perng, RP;Kohno, T;Kweon, S; et al. |
| 中國醫藥大學 |
2012-09 |
Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia.
|
(Hosgood HD 3rd);(Wang WC);(Hong YC);(Wang JC);(Chen K);(Chang IS); (Chen CJ);(Lu D);(Yin Z);(Wu C);(Zheng W);(Qian B);(Park JY); (Kim YH);(Chatterjee N);(Chen Y);(Chang GC);(Hsiao CF) (Yeager ;M);(Tsai YH); (Wei H);(Kim YT);(Wu W);(Zhao Z);(Chow WH); (Zhu X);(Lo YL); (Sung SW);(Chen KY);(Yuenger J);(Kim JH);(Huang L); (Chen YH);(Gao YT);(Kim JH);(Huang MS);(Jung TH);(Caporaso N);(Zhao X); (Huan Z);(Yu D); (Kim CH);(Su WC); (Shu XO);(Kim IS);(Bassig B); (Chen YM);(Cha SI); (Tan W);(Chen H);(Yang TY);(Sung JS);(Wang CL); (Li X);(Park KH);(Yu CJ);(Ryu JS);(Xiang Y);(Hutchinson A);(Kim JS);(Cai Q); (Landi MT);(Lee KM); (Hung JY);(Park JY);(Tucker M);(Lin CC);(Ren Y);(Perng RP);陳志毅(Chih-Yi Chen);(Jin L);(Chen KC);(Li YJ); (Chiu YF);(Tsai FY);(Yang PC);(Fraumeni JF Jr); (Seow A);(Lin D);(Zhou B);(Chanock S);(Hsiung CA);(Rothman N);(Lan Q)* |
| 國家衛生研究院 |
2012-07 |
Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia
|
Hosgood, HD, 3rd;Wang, WC;Hong, YC;Wang, JC;Chen, K;Chang, IS;Chen, CJ;Lu, D;Yin, Z;Wu, C;Zheng, W;Qian, B;Park, JY;Kim, YH;Chatterjee, N;Chen, Y;Chang, GC;Hsiao, CF;Yeager, M;Tsai, YH;Wei, H;Kim, YT;Wu, W;Zhao, Z;Chow, WH;Zhu, X;Lo, YL;Sung, SW;Chen, KY;Yuenger, J;Kim, JH;Huang, L;Chen, YH;Gao, YT;Huang, MS;Jung, TH;Caporaso, N;Zhao, X;Huan, Z;Yu, D;Kim, CH;Su, WC;Shu, XO;Kim, IS;Bassig, B;Chen, YM;Cha, SI;Tan, W;Chen, H;Yang, TY;Sung, JS;Wang, CL;Li, X;Park, KH;Yu, CJ;Ryu, JS;Xiang, Y;Hutchinson, A;Kim, JS;Cai, Q;Landi, MT;Lee, KM;Hung, JY;Tucker, M;Lin, CC;Ren, Y;Perng, RP;Chen, CY;Jin, L;Chen, KC;Li, YJ;Chiu, YF;Tsai, FY;Yang, PC;Fraumeni, JF, Jr.;Seow, A;Lin, D;Zhou, B;Chanock, S;Hsiung, CA;Rothman, N;Lan, Q |
| 高雄醫學大學 |
2011 |
Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Multicenter Study.
|
黃明賢; Fan WC;Yu CJ;Tsai CM;Huang MS;Lai CL;Hsia TC;Tien YJ;Huang SF;Wu CH;Chou KT;Lee YC;Perng RP;Chen YM. |
| 國家衛生研究院 |
2010-08 |
The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia
|
Hsiung, CA;Lan, Q;Hong, YC;Chen, CJ;Hosgood, HD;Chang, IS;Chatterjee, N;Brennan, P;Wu, C;Zheng, W;Chang, GC;Wu, T;Park, JY;Hsiao, CF;Kim, YH;Shen, H;Seow, A;Yeager, M;Tsai, YH;Kim, YT;Chow, WH;Guo, H;Wang, WC;Sung, SW;Hu, Z;Chen, KY;Kim, JH;Chen, Y;Huang, L;Lee, KM;Lo, YL;Gao, YT;Liu, L;Huang, MS;Jung, TH;Jin, G;Caporaso, N;Yu, D;Kim, CH;Su, WC;Shu, XO;Xu, P;Kim, IS;Chen, YM;Ma, H;Shen, M;Cha, SI;Tan, W;Chang, CH;Sung, JS;Zhang, M;Yang, TY;Park, KH;Yuenger, J;Wang, CL;Ryu, JS;Xiang, Y;Deng, Q;Hutchinson, A;Kim, JS;Cai, Q;Landi, MT;Yu, CJ;Tucker, M;Hung, JY;Lin, CC;Perng, RP;Boffetta, P;Chen, CY;Chen, KC;Yang, SY;Hu, CY;Chang, CK;Fraumeni, JF, Jr.;Chanock, S;Yang, PC;Rothman, N;Lin, D |
| 國家衛生研究院 |
2008-08 |
A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
|
Chen, YM;Perng, RP;Shih, JF;Whang-Peng, J |
| 國家衛生研究院 |
2008-01 |
Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy
|
Chou, KT; Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J |
| 高雄醫學大學 |
2008 |
High efficacy of erlotinib in Taiwanese NSCLC patients in an exp;ed access program study previously treated with chemotherapy
|
黃明賢; Perng RP;Yang CH;Chen YM;Chang GC;Lin MC;Hsieh RK;Chu NM;Lai RS;Su WC;Tsao CJ;Hsia TC;Chen HC;Chen CH;Huang MS;Wang JL;Ho ML;Chung CY;Yu CJ;Chang WC;Kuo HP;Yu CT;Lin ZZ;Kao WY. |
| 國家衛生研究院 |
2007-10-15 |
Hormone replacement therapy and lung cancer risk in Chinese
|
Chen, KY; Hsiao, CF; Chang, GC; Tsai, YH; Su, WC; Perng, RP; Huang, MS; Hsiung, CA; Chen, CJ; Yang, PC |
| 國家衛生研究院 |
2007-06 |
A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naive non-small-cell lung cancer in Taiwan
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2007-05 |
Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy
|
Chen, YM;Liu, JM;Chou, TY;Perng, RP;Tsai, CM;Whang-Peng, J |
| 國家衛生研究院 |
2007-03 |
Effect of age on pulmonary metastases and immunotherapy in young and middle-aged mice
|
Chen, YM;Wang, PS;Liu, JM;Hsieh, YL;Tsai, CM;Perng, RP;Whang-Peng, J |
| 高雄醫學大學 |
2007 |
Hormone replacement therapy;lung cancer risk in Chinese.
|
黃明賢; Chen KY;Hsiao CF;Chang GC;Tsai YH;Su WC;Perng RP;Huang MS;Hsiung CA;Chen CJ;Yang PC;GEFLAC Study Group |
| 國家衛生研究院 |
2006-07 |
Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-06 |
A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
|
Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-04 |
A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy
|
Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-02 |
A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
|
Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-01 |
Leukotriene C-4 induces TGF-beta(1) production in airway epithelium via p38 kinase pathway
|
Perng, DW;Wu, YC;Chang, KT;Wu, MT;Chiou, YC;Su, KC;Perng, RP;Lee, YC |
| 高雄醫學大學 |
2006 |
Double-blind r;omized parallel group study comparing the efficacy;safety of tiotropium;ipratropium in the treatment of COPD patients in Taiwan.
|
黃明賢; Hsu JY;Perng RP;Lu JY;Wu CP;Huang MS;Luh KT;Yang PC. |
| 國家衛生研究院 |
2005-07 |
Chemotherapy for non-small cell lung cancer in elderly patients
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2005-06 |
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer
|
Tsai, CM;Chiu, CH;Chou, TY;Li, LH;Hsiao, CY;Chen, M;Perng, RP;Tsai, SF |
| 國家衛生研究院 |
2005-06 |
A phase II trial of UFUR plus gemcitabine in non-small cell lung cancer patients failing previous platinum-based chemotherapy
|
Chen, YM;Perng, RP;Tsai, CM;Whang-Peng, J |
| 國家衛生研究院 |
2005-05-15 |
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer
|
Chou, TY; Chiu, CH; Li, LH; Hsiao, CY; Tzen, CY; Chang, KT; Chen, YM; Perng, RP; Tsai, SF; Tsai, CM |
| 國家衛生研究院 |
2005-03 |
A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2004-07 |
Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms
|
Chen, YM; Perng, RP; Chu, H; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2004-07 |
Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy
|
Chen, YM;Shih, JF;Tsai, CM;Perng, RP;Whang-Peng, J |
| 國家衛生研究院 |
2004-02-26 |
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Shih, JF; Lee, YC; Lee, CS; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2003-12 |
Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy
|
Chen, YM; Perng, RP; Lee, CS; Lin, WC; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2003-05 |
A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older
|
Chen, YM; Perng, RP; Chen, MC; Tsai, CM; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
2003-02 |
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel
|
Chen, YM; Shih, JF; Lee, CS; Chen, MC; Lin, WC; Tsai, CM; Perng, RP |
| 國家衛生研究院 |
2002-10 |
Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
|
Chen, YM; Perng, RP; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2002-10 |
Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
| 國家衛生研究院 |
2002-02 |
Additive effect of interleukin-12 and interleukin-18 on the T-helper cell pathway of malignant pleural effusion
|
Yao, NS; Chen, YM; Perng, RP; Whang-Peng, J |
| 國家衛生研究院 |
2002-01 |
Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Lee, YC; Shih, JF; Lee, CS; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2001-04 |
Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: Comparison of malignant and tuberculous pleural effusions
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
| 國家衛生研究院 |
2001-01 |
An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer
|
Chen, YM; Yang, WK; Whang-Peng, J; Tsai, CM; Perng, RP |
| 臺北醫學大學 |
2001 |
Childhood tuberculosis presenting as an anterior chest wall abscess
|
黃群耀; Huang CY; Su WJ; Perng RP; |
| 臺北醫學大學 |
2001 |
Utility of PCR assays for rapid diagnosis of BCG infection in children
|
黃群耀; Su WJ; Huang CY; Perng RP; |
| 國家衛生研究院 |
2000-12 |
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
|
Chen, YM; Perng, RP; Whang-Peng, J; Wu, HW; Lin, WC; Tsai, CM |
| 國家衛生研究院 |
2000-09 |
Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer
|
Wang, PC; Yang, KY; Chao, JY; Liu, JM; Perng, RP; Yen, SH |
| 國家衛生研究院 |
2000-08 |
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2000-06 |
A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Liu, TW; Tsai, CM; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer
|
Perng, RP; Shih, JF; Chen, YM; Delgado, FM; Tsai, CM; Chou, KC; Liu, JM; Chern, MS; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Liu, JM; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2000-01 |
Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: Interleukin-15 vs. interleukin-2
|
Chen, YM; Ting, CC; Peng, JW; Yang, WK; Yang, KY; Tsai, CM; Perng, RP |
| 國家衛生研究院 |
2000 |
Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT)
|
Chen, YM;Perng, RP;Whang-Peng, J;Lin, WC;Wu, HW;Tsai, CM |
| 國家衛生研究院 |
1999-09 |
A multi-centre phase II trial of gemcitabine (GEM) and vinorelbine (VRL) in patients (PTS) with stage III-IV non small cell lung cancer (NSCLC)
|
Chen, YM;Perng, RP;Peng, JW;Liu, TW;Yang, KY;Lin, WC;Wu, HW;Shih, JF;Liu, JM;Chen, LT;Tsai, CM |
| 國家衛生研究院 |
1998-03 |
Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions
|
Perng, RP; Chen, YM; Wu, MF; Chou, KC; Lin, WC; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
1997-10 |
Cross regulation by IL-10 and 1L-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients
|
Chen, YM; Yang, WK; Ting, CC; Tsai, WY; Yang, DM; WhangPeng, J; Perng, RP |
| 國家衛生研究院 |
1997-09 |
Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients
|
Chen, YM; Yang, WK; WhangPeng, J; Tsai, WY; Hung, YM; Yang, DM; Lin, WC; Perng, RP; Ting, CC |
顯示項目 6-55 / 58 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
